Pharmaceutical Executive
The importance of early development strategy and planning for biologic patent term extension.
Micheal Binns
Advertisement
Articles by Micheal Binns
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
3
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
4
Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics
5